Clinical trial
Prediction of Preterm Delivery by Serum Ischemia Modified Albumin, Biglycan and Decorin Levels in Women With Threatened Preterm Labour
NCT04451928 is registered in ClinicalTrials.gov with Ismail Biyik as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prediction of Preterm Delivery by Serum Ischemia Modified Albumin, Biglycan and Decorin Levels in Women With Threatened Preterm Labour
- Lead sponsor
- Ismail Biyik
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2019
- Completion date
- February 5, 2021
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
preterm birth